The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Importance of the Noradrenaline–Dopamine Coupling in the Locomotor Activating Effects of d-Amphetamine
Open accessAbstract
The locomotor hyperactivity induced by systemic or local (nucleus accumbens)d-amphetamine injections can be blocked by systemic or local (prefrontal cortex) injections of prazosin, an α1-adrenergic antagonist (Blanc et al., 1994). Microdialysis studies performed on freely moving animals indicated that prazosin (0.5 mg/kg, i.p.) does not modify the increase in the extracellular dopamine (DA) levels in the nucleus accumbens that are induced by d-amphetamine (2.0 mg/kg, i.p.), but it inhibits the d-amphetamine-induced locomotor hyperactivity (−63%,p< 0.0001). No behavioral activation occurred after the bilateral local perfusion of 3 μ md-amphetamine in the nucleus accumbens, although it led to a fivefold increase in extracellular DA levels. This increase in extracellular DA levels was not affected by prazosin (0.5 mg/kg, i.p.). When an intraperitoneal injection of d-amphetamine (0.5 mg/kg) was superimposed to the continuous local perfusion of 3 μ md-amphetamine, it induced a 64% increase in the extracellular DA levels in the nucleus accumbens, and this response was associated with simultaneous behavioral activation. Both the increases in extracellular DA levels and in locomotor activity were completely blocked by a pretreatment with prazosin, injected either systemically (0.5 mg/kg, i.p.) or locally and bilaterally into the prefrontal cortex (500 pmol/side). Complementary experiments indicated that the focal application of d-amphetamine requires at least a 4.8-fold higher increase in DA output compared with systemic d-amphetamine for the behavioral effects to be elicited. Altogether, these results suggest that locomotor activating effects of d-amphetamine are caused by the stimulation of cortical α1-adrenergic receptors by noradrenaline, which increases the release of a functional part of subcortical DA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kelly, P. H., Seviour, P. W., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90233-4 · Cited by 1,731
International Union of Pharmacology nomenclature of adrenoceptors.
Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., Molinoff, P. B., Ruffolo, R. R., & Trendelenburg, U. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06780-8 · Cited by 1,218
On the significance of subterritories in the “accumbens” part of the rat ventral striatum
Zahm, D. S., & Brog, J. S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90202-d · Cited by 1,040
Sesack, S. R., & Pickel, V. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903200202 · Cited by 820
Noradrenergic neurons: Morphine inhibition of spontaneous activity
Korf, J., Bunney, B. S., & Aghajanian, G. K. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90045-4 · Cited by 431
Murase, S., Grenhoff, J., Chouvet, G., Gonon, F. G., & Svensson, T. H. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90641-w · Cited by 387
Karreman, M., & Moghaddam, B. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020589.x · Cited by 357
The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action
Andersen, P. H. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90363-4 · Cited by 346
Pijnenburg, A. J. J., Honig, W. M. M., & Van Rossum, J. M. (1975) · Psychopharmacologia · doi:10.1007/bf00421062 · Cited by 330
Amphetamine psychosis: Behavioral and biochemical aspects
Angrist, B., Sathananthan, G., Wilk, S., & Gershon, S. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90064-8 · Cited by 326
Cited by
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529
A review of the clinical pharmacology of methamphetamine
Cruickshank, C. C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 769
Catecholamine modulation of prefrontal cortical cognitive function
Arnsten, A. F. T. (1998) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(98)01240-6 · Cited by 604
Goodman, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 413
Sarter, M., & Bruno, J. P. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00487-x · Cited by 413
Metadata
- Authors
- Darracq, L., Blanc, G., Glowinski, J., & Tassin, J.-P.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1998-04-01
- Volume
- 18
- Issue
- 7
- Pages
- 2729-2739
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1893531325
- Cited by
- 256
- References
- 46
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Importance of the Noradrenaline–Dopamine Coupling in the Locomotor Activating Effects of d-Amphetamine. https://app.cochat.ai/papers/10.1523/jneurosci.18-07-02729.1998
- The paper
- Darracq, L., Blanc, G., Glowinski, J., & Tassin, J.-P. (1998). Importance of the Noradrenaline–Dopamine Coupling in the Locomotor Activating Effects of d-Amphetamine. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.18-07-02729.1998
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.